TTY Biopharm Company Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2017

In its 2023 reporting, TTY Biopharm Company Limited disclosed greenhouse gas emissions of 12.7K tCO2e/year. By scope: Scope 1: 1.7K tCO2e/year; Scope 2: 8.5K tCO2e/year; Scope 3: 2.5K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
12.7K tCO2e/year
2023
💧
Water Usage
153.4M m3/year
2023
♻️
Waste
43.27 tons/year
2023
⚙️
Energy Use
78.1M MWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).1.7K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.8.5K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).2.5K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202312.7K tCO2e/year
20177.1K tCO2e/year (Scope 1 and 2 combined)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Organize 2 environmental sustainability promotions every year
  • Conserve 2% electricity annually
  • Recycle 5 tons of waste resources

📅 Medium-term

  • Explore technologies to improve environmental sustainability
  • Evaluate purchase of green energy and energy-efficient equipment
  • Carry out water resources recycling
  • Achieve 8% or more carbon reduction by 2030 compared to base year 2022

🔭 Long-term

  • Green building plan for the future
  • Establish a green supplier management system
  • Join climate initiative organization or alliance

🌱 ESG Focus Areas

Steady Development of the CompanyRealization of a Healthy SocietyPromotion of the Green Transformation

⚠️ Challenges & Risks +

  • Competition in the pharmaceutical market
  • Risks related to product and technology development
  • Risks to the company's image and reputation
  • Risks related to integrity and ethics
  • Climate change impacts (typhoons, floods, rising temperatures, water scarcity)

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards 2021, SASB, TCFD, UNGC
Assurance: Afnor Asia Ltd., DNV Business Assurance